Substituted amidoalkyl uracils and their use as inhibitors...

Details Substituted amidoalkyl uracils and their use as inhibitors... Substituted amidoalkyl uracils and their use as inhibitors...

2006-10-24

2006-10-24

McKenzie, Thomas C. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S284000, C544S285000, C514S252160, C514S260100, C514S266210, C514S266300

Reexamination Certificate

active

07125995

ABSTRACT:
This application relates to compounds of formula (I) belowin which the several variable groups are as defined in the specification and claims, to methods of preparing these materials, to pharmaceutical compositions containing these materials, and to methods of using these materials to treat ischaemia or reperfusion damage.

REFERENCES:
patent: 5426186 (1995-06-01), Shaw et al.
patent: 5859014 (1999-01-01), Bantle et al.
patent: 1959705 (1971-06-01), None
patent: 2126148 (1972-12-01), None
patent: 2142317 (1973-03-01), None
patent: 1142881 (2001-10-01), None
patent: 03264579 (1991-11-01), None
patent: 9702254 (1997-01-01), None
patent: 0042025 (2000-07-01), None
Steinhagen, Henning; Gerisch, Michael; Mittendorf, Joachim; Schlemmer, Karl-Heinz; Albrecht, Barbara, Bioorganic & Medicinal Chemistry Letters 12(21), 3187-3190 (English) 2002.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Peukert, Stefan, et al, Expert Opin. Ther. Patents, 2004, 14(110, 1531-1551.
Larner, Andrew J., Expert. Opin. Ther. Patents 2002, 12(4), 481-487.
Szabó et al., “Role of poly(ADP-ribose) Synthetase in Inflammation and Ischaemia-reperfusion.” TIPS, 19, 287-298 (1998).
Zhang, et al. “Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity.” Science, 263, 687-689 (1994).
Wallis, et al., Neuroprotection Against Nitric Oxide Injury with Inhibitors of ADP-ribosylation, NeuroReport, 5, 245-248 (1993).
Endres, et al., Ischemic Brain Injury Is Mediated by the Activation Of Poly (ADP-Ribose) Polymerase. J. Cereb. Blood Flow Metabol., 17, 1143-1151 (1997).
Wallis et al., Traumatic Neuroprotection with Inhibitors of Nitric Oxide and ADP-ribosylation. Brain Res., 710, 169-177 (1996).
Thiemermann et al., “Inhibition of the Activity of Poly (ADP ribose) Synthetase Reduces Ischemia-Reperfusion Injury in the Heart and Skeletal Muscle”, Proc. Nat. Acad. Sci., 94, 679-683 (1997).
Shimabukuro, et al., “Role of Nitric Oxide in Obesity-Induced β Cell Disease”. J. of Clin. Invest. 100, 290-295 (1997).
Zingarelli, et al., “Protective Effects of Nicotinamide against Nitric Oxide-Mediated Delayed Vascular Failure in Endotoxic Shock: Potential Involvement of polyADP Ribosyl Synthetase”, SHOCK, 5, 258-264 (1996).
Weltin, et al, Effect of 6(5H)-Phenanthridinone, an Inhibitor of Poly(ADP-ribose) Polymerase, on Cultured Tumor Cells, Oncology Res. 6, 399-403 (1994).
Jijon et al., Inhibiton of poly(ADP-ribose)Polymerase Attenuates Inflammation in a Model of Chronic Colitis. Am. J. Physiol Gastrointest Liver Physiol. 279, G641-G651, (2000).
Tambuchi, et al., “Poly (Adenosine Diphosphate-Ribose) Synthetase Inhibitor 3-Aminobenzamide Alleviates Cochlear Dysfunction Induced by Transient Ischemia.” Ann Otol Rhinol Laryngol, 110, 118-121, (2001).
Cuzzocrea, et al., “Protective Effects of 3-aminobenzamide, an Inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced Model of local inflammation.” Eur. J. of Pharma., 342 67-76, (1998).
Eriksson, et al., “3-Aminobenzamide: Effects On Cytochtome P450-Dependent Metabolism of Chemicals and on the Toxicity of Dichlobenil In the Olfactory Mucosa.”, Toxic.and App. Pharma. 136, 324-331, (1996).
Watanabe, et al., “Syntheses of Monocyclic and Bicyclic 2,4(1H, 3H)-Pyrimidinediones and Their Serotonin 2 Antagonist Activities.”, Chem. Pharm. Bull. 38, 2726-2732, (1990).
Basnak, I., “The Synthesis of some 5-Substituted and 5,6-Disubstituted 2'-Deoxyuridines.”, Nucleosides & Nucleotides, 13(1-3), 177-196 (1994).
Renault, et al., Syntheseis and antiviral study of Cyclopentano [d] Pyrimidine-2,4-Diones and Octahydroquinazoline-2,4-Diones Acyclic Nucleosides and Potential Anti-Hiv Agents, Nucleosides & Nucleotides, 13(4), 891-901 (1994).
Rahim, et al., “Synthesis and Anti-Herpes Virus Activity of 2'-Deoxy-4'-Thiopyrimidine Nuceolsides,” J. Med. Chem., 39, 89-795, (1996).
Peczak, et al., “Alkylated Derivatives of Uracil, Part X*, Synthesis of 2,4-Diketo-5,6,7,8-Tetrahydroquinazoline**,” Pol. J. of Chem., 59, 317-326, (1985).
Draminski, et al., “Alkylated Derivatives of Uracil, Part IX*, Synthesis of N-(2,3-Dihydroxypropyl) Derivatives of 5,6-Tertramethyleneuracil, Structural Analogs of Nucleosides,” Pol. J. Chem. 55, 1547-1552, (1981).
Szabo, et al., Protective Effect of an Inhibitor of Poly (ADF Ribora) Synthesis—Collagen-induced Arthritis, Japanese J. Pharm., 75, Supp 1:102 (1997).

Affiliated with

Also associated with

Rating

Substituted amidoalkyl uracils and their use as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted amidoalkyl uracils and their use as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted amidoalkyl uracils and their use as inhibitors... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3708822